Rebound Momentum

Rebound Momentum Scans & Deep-Dive Trade Setup Matrix

Scan Date: October 20, 2026 | Profile: Default Rebound (Hits = 30)

Our quantitative Rebound algorithm targets high-momentum stocks undergoing healthy, short-term pullbacks from recent highs. These setups aim to capture trend continuation entries while maintaining strictly defined risk parameters.

Screener Data Output

Rebound hits=30 profile=default · 2026-10-20 23:23 SYM SCR PRICE DD RSI ATR ---- --- ------ ---- --- ---- MRNA 178 226.89 -6% 64 8.2% CDNA 156 67.08 -8% 63 6.4% TRMD 153 38.05 -10% 52 4.8% CHEF 152 111.28 -6% 50 3.8% GKOS 142 173.43 -10% 58 4.6% EQNR 140 45.25 -4% 56 3.6% AMRX 140 19.36 -9% 51 3.3% KNSA 137 79.48 -4% 57 3.5% XP 137 30.26 -8% 71 5.9% GCT 136 58.93 -2% 65 4.3% CVE 133 33.26 -5% 59 3.4% UGP 132 7.77 -6% 59 3.6% SN 129 188.94 -4% 59 3.0% TRGP 128 292.80 -5% 56 2.6% EC 126 17.77 -3% 58 2.6% PACS 126 45.85 -7% 60 3.3% PR 124 24.79 -2% 65 3.3% FIGS 123 19.45 -4% 78 5.4% TBBB 122 57.20 -4% 64 3.1% CAKE 121 116.45 -2% 65 3.0% GTE 118 11.38 -1% 70 3.3% NUE 118 260.73 -7% 60 2.7% PSX 117 290.55 -3% 68 3.2% PBR 114 25.56 -2% 71 3.3% APA 114 49.76 -0% 71 3.1% CHRD 113 154.48 -2% 68 2.7% EXEL 112 62.68 -1% 69 2.8% CON 112 38.18 -4% 66 2.6% SLDE 111 27.12 -1% 72 3.0% DRH 109 14.07 -0% 72 2.9%

Market Context & Key Findings

The current scan reveals strong sector clustering and well-defined technical setups across leadership groups:

• Sector Concentration: Heavy leadership in Energy (EQNR, CVE, EC, TRGP, PR, PSX, PBR, APA, CHRD) and Biotech/Healthcare (MRNA, CDNA, TRMD, GKOS, AMRX, KNSA, EXEL, PACS).
• Pullback Profile: Drawdowns are controlled (0% to -10%), with RSIs mostly hovering between 50 and 78, reflecting orderly consolidation rather than structural damage.
• High Momentum vs. Volatility: Top-ranked MRNA holds the highest score (178) with an 8.2% ATR, requiring wider stop-loss buffers compared to steady, low-ATR trenders like TRGP (2.6% ATR).

Rebound Trade Setup Matrix

The matrix below details key entry zones, stop-loss levels, profit targets, and risk-to-reward metrics calculated using volatility bounds (Daily ATR).

Ticker	Current Price	Entry Zone	Stop Loss	Potential Loss (%)	Target Exit (TP1)	Target Exit (TP2)	Potential Gain (%)	Risk / Reward	Chart
MRNA	$226.89	$215.00 – $225.00	$197.50	-8.1%	$255.00	$280.00	+13.3% to +24.4%	1 : 1.6 to 1 : 3.0	MRNA Chart
CDNA	$67.08	$64.00 – $66.50	$60.00	-7.7%	$75.00	$82.00	+15.4% to +26.2%	1 : 2.0 to 1 : 3.4	CDNA Chart
TRMD	$38.05	$36.50 – $37.80	$34.50	-6.8%	$42.00	$46.00	+13.5% to +24.3%	1 : 2.0 to 1 : 3.6	TRMD Chart
CHEF	$111.28	$108.00 – $110.50	$103.00	-5.9%	$120.00	$128.00	+9.1% to +16.4%	1 : 1.5 to 1 : 2.8	CHEF Chart
GKOS	$173.43	$168.00 – $172.00	$158.00	-7.1%	$190.00	$205.00	+11.8% to +20.6%	1 : 1.7 to 1 : 2.9	GKOS Chart
XP	$30.26	$28.50 – $29.80	$26.80	-7.6%	$34.00	$37.50	+14.1% to +25.8%	1 : 1.9 to 1 : 3.4	XP Chart
TRGP	$292.80	$285.00 – $290.00	$275.00	-4.4%	$315.00	$335.00	+9.5% to +16.4%	1 : 2.2 to 1 : 3.7	TRGP Chart

Execution & Risk Management Guidelines

• Stop-Loss Placement: Stops are structured approximately 1.25x to 1.5x ATR below entry ranges to accommodate expected intra-day price swings.
• Position Sizing: Scale position size inversely to volatility. High-ATR assets like MRNA and CDNA require smaller dollar exposure to maintain standard account risk.
• Profit Targets: Consider locking in partial profits at TP1 (prior resistance/swing highs) and letting remaining runners trail toward TP2 extensions.

Disclaimer: This content is provided for informational and educational purposes only and does not constitute financial, investment, or trading advice. Trading equities, options, and volatile assets carries substantial risk of loss. Always conduct independent research and consult a certified financial advisor or professional before executing trade setups.